Tenet Healthcare Corporation ($THC) Stock Forecast: Up 6.6% Today

What is Tenet Healthcare Corporation?

Tenet Healthcare Corporation (THC) operates healthcare services facilities nationwide, with a focus on delivering top-tier patient care and enhancing healthcare outcomes.

Why is Tenet Healthcare Corporation going up?

THC stock is up 6.6% on Jun 11, 2026 17:56

• Despite technical analysis pointing towards a "Strong Sell" sentiment and bearish momentum, THC saw a significant bullish surge in the market today.
• A credit upgrade to Ba2 by Moody's, coupled with a stable outlook, showcased Tenet Healthcare's successful debt reduction efforts and strong EBITDA, underscoring its emphasis on ambulatory care.
• The recent positive credit upgrade and robust Q1 2026 performance may have instilled greater investor confidence in THC, driving the bullish market movement.
• Investors are advised to remain vigilant about potential risks such as subdued future earnings projections, elevated leverage, and insider selling, notwithstanding the favorable developments.

THC Price Chart

THC Technical Analysis

THC News

THC Technical Analysis & Stock Price Forecast

Tenet Healthcare Corp (THC) currently shows a "Strong Sell" technical sentiment based on an aggregation of 10 technical signals with 8 indicating sell and 2 indicating buy. Key indicators like the MACD and various moving averages suggest bearish momentum, with THC trading below its 60-day and 200-day moving averages. The article also provides specific support and resistance levels for traders to monitor.

https://intellectia.ai/en/stock/THC/technical

Did Moody’s Credit Upgrade Just Reframe Tenet Healthcare’s (THC) Deleveraging Story for Investors?

Moody’s recently upgraded Tenet Healthcare Corporation's credit rating to Ba2 with a stable outlook, acknowledging the company's sustained deleveraging efforts, strong EBITDA, and debt reduction. While this validates Tenet's disciplined financial policies and focus on ambulatory care, the article notes that investors still need to consider operational execution, projected earnings softening, and governance concerns like high CEO pay and insider selling. Despite the upgrade, some analyses suggest Tenet's shares might still be overvalued.

https://sg.finance.yahoo.com/news/did-moody-credit-upgrade-just-171521556.html

Does Tenet Healthcare’s (THC) Credit Upgrade Quietly Redefine Its Ambulatory‑First Investment Story?

Tenet Healthcare Corporation (THC) recently received a credit upgrade from Moody’s, moving its Corporate Family Rating to Ba2 from Ba3, citing sustained deleveraging and strong EBITDA. This upgrade reinforces the company's investment narrative focused on high-margin ambulatory care, strategic buybacks, and debt management. While the upgrade and strong Q1 2026 results are positive catalysts, investors should also consider risks like softer future earnings forecasts, high leverage, and insider selling.

https://www.sahmcapital.com/news/content/does-tenet-healthcares-thc-credit-upgrade-quietly-redefine-its-ambulatoryfirst-investment-story-2026-06-07

Tenet Healthcare Corporation (THC) is a trending stock: Facts to know before betting on it

This article identifies Tenet Healthcare Corporation (THC) as a currently trending stock. It advises potential investors to understand key facts about the company before making an investment decision. The content will likely delve into various aspects of THC's financial health, market position, or recent performance.

https://www.msn.com/en-us/money/topstocks/tenet-healthcare-corporation-thc-is-a-trending-stock-facts-to-know-before-betting-on-it/ar-AA24QcD9

Tenet Healthcare Corporation Balance Sheet – XETR:THC1

Tenet Healthcare Corporation's financial position for Q1 26 shows total assets of ‪27.01 B‬ EUR, a 6.88% increase from Q4 25. Total liabilities also rose by 9.75% to ‪19.35 B‬ EUR in the same quarter. The report provides an overview of the company's balance sheet, income statement, and cash flow data, with historical figures available up to Q4 25.

https://www.tradingview.com/symbols/XETR-THC1/financials-balance-sheet/

Trending Today

CarMax Inc ($KMX) Stock Forecast: Up 10.0% Today

Northrop Grumman Corporation ($NOC) Stock Forecast: Down 6.1% Today

Micron Technology Inc. ($MU) Stock Forecast: Up 6.4% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 5.4% Today

Omnicom Group Inc. ($OMC) Stock Forecast: Down 5.1% Today

Cognizant Technology Solutions Corporation ($CTSH) Stock Forecast: Down 11.4% Today

Texas Instruments Incorporated ($TXN) Stock Forecast: Up 5.1% Today

SoFi Technologies Inc. ($SOFI) Stock Forecast: Down 5.2% Today

Moderna Inc. ($MRNA) Stock Forecast: Up 5.5% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 10.2% Today

Tenet Healthcare Corporation Price History

31.02.2026 - THC Stock was down 4.2%

• A decision to disaggregate holdings and report 0% ownership of Tenet Healthcare (THC) by a major institutional investor may have signaled a lack of confidence in the company's future performance, leading to a bearish sentiment among investors.
• An internal realignment within the mentioned institutional investor, resulting in subsidiaries reporting ownership separately, could have created uncertainty and potentially triggered selling pressure on THC shares.
• Investors may interpret this institutional investor's move as a strategic shift away from healthcare stocks like THC, contributing to the bearish movement in the company's stock price today.

01.04.2026 - THC Stock was up 5.1%

• Tenet Healthcare's Q1 earnings surpassed expectations, showing resilience despite challenges like a soft flu season, winter storms, and a cybersecurity event.
• Growth in joint replacements and ASC acquisitions drove strong performance in the company's USPI segment, contributing to the bullish movement in its stock.
• Strategic investments in technology and AI, as well as reaffirmed guidance for 2026, have boosted investor confidence in Tenet Healthcare's long-term growth prospects, despite slight concerns about overvaluation.
• Vanguard's significant stake in the company underlines investor faith in its future potential and strategic direction, bolstering positive sentiment around the stock.

01.04.2026 - THC Stock was up 7.2%

• Investors remained positive even after RBC's price target cut on THC, as the company's Q1 earnings surpassed expectations, demonstrating resilience and growth prospects.
• Challenges like a mild flu season and an unfavorable mix of payers affected sales, but THC's strategic investments in its USPI segment and efficient operations boosted investor sentiment.
• CEO Saum Sutaria's focus on managing volume disruptions with traditional methods proved successful, underscoring THC's capability to maintain healthy margins through effective cost control.
• Despite obstacles, THC's decision to maintain its full-year guidance reflects a sound long-term strategy and confidence in its diversified asset portfolio.

21.04.2026 - THC Stock was down 6.1%

• A legal dispute between Tenet hospitals and The Leapfrog Group over hospital ratings and associated legal fees may have created uncertainty and negative sentiment around Tenet Healthcare, leading to the bearish movement in the stock.
• Positive foot traffic data for Tenet Healthcare in April was overshadowed by the ongoing legal battle and potential financial implications from the dispute, contributing to the bearish market movement.
• Concerns about the impact of escalating legal fees on Tenet Healthcare's financial health and operational efficiency led investors to sell off the stock due to uncertainties surrounding the company's future prospects.

19.04.2026 - THC Stock was down 5.8%

• Positive April data for Tenet Healthcare from Bank of America did not lead to a bullish market response, hinting at other influencing factors on the stock's performance.
• Despite surpassing consensus estimates in foot traffic growth, THC underwent a bearish trend, implying that investors might be responding to different market dynamics.
• The neutral outlook for HCA Healthcare from the same report indicates that industry-specific factors may not be the main driver behind THC's bearish movement.
• It is conceivable that factors beyond industry-specific news contributed to the negative sentiment surrounding Tenet Healthcare's stock on this particular day.

30.03.2026 - THC Stock was down 5.5%

• THC stock witnessed a notable downward trend, decreasing by 5.8% to conclude at $177.38.
• The drop was not linked to any company-specific developments but was part of a broader sector-wide decline impacting hospital operators like HCA and Universal Health Services.
• Investors might be reconsidering the healthcare sector in light of macroeconomic factors such as reimbursement trends or cost pressures, leading to a synchronized industry downturn.
• Despite recent positive financial performance and growth projections outlined in recent assessments, the overvaluation of THC stock and broader industry worries likely played a role in the bearish market movement.

14.03.2026 - THC Stock was up 5.3%

• THC stocks fell by 3.28% despite surpassing Q4 2025 earnings expectations, likely due to cautious 2026 guidance predicting a 20% decline in exchange marketplace enrollment.
• The substantial trading volume indicates a significant debate between bullish investors emphasizing operational strength and M&A strategy, and bearish investors worried about future regulatory and macroeconomic obstacles.
• Despite a 3.3% decrease to $195.24, suggesting overvaluation, there appears to be a gap between market price and intrinsic value, with insider selling contributing to investor hesitancy.
• The retirement announcement of Paola Arbour, Tenet Healthcare's EVP & CIO, though not directly linked to the current market movement, may hint at potential executive changes that investors are monitoring closely.

24.03.2026 - THC Stock was down 8.4%

• The bearish movement in THC stock could be attributed to underperforming the S&P 500, declining by 2.74% in the latest trading session.
• Investors might be reacting to the upcoming earnings report on April 30, 2026, with analysts expecting an EPS of $4.19 and revenue of $5.39 billion, which could be causing uncertainty and selling pressure.
• The emphasis on mobile-first delivery of financial news by Google's 2026 Discover Core Update could be impacting investor sentiment, with tailored insights on THC's performance and strategic shifts towards ambulatory care and revenue management potentially influencing trading decisions.
• The market's reaction to the mobile-first approach could be signaling a shift in investor behavior towards more proactive and concise information delivery, impacting stock movements like THC's bearish trend today.

24.02.2026 - THC Stock was down 5.2%

• The bearish movement in THC's stock price could be attributed to the overall decline in the healthcare sector, as evidenced by the recent 10.1% drop in the stock over the last month.
• Despite beating earnings expectations and holding a "Moderate Buy" consensus rating from analysts, insider selling and the reduction in stake by institutional investors like Cambria Investment Management L.P. might have contributed to the negative sentiment surrounding THC.
• The market's reaction to THC's strong quarterly earnings report could indicate that investors are focusing more on the recent insider selling and institutional adjustments rather than the company's financial performance.
• The combination of these factors, along with the broader market and sector drops, likely led to the bearish movement in THC's stock price despite its positive earnings report.

02.05.2026 - THC Stock was down 5.1%

• The bearish movement in THC's stock price today can be attributed to the significant insider selling activity by director J. Robert Kerrey, who sold 5,638 shares totaling $983,920. This large sell-off may have raised concerns among investors about the company's future prospects.
• Despite the director's sale, the company has shown strong financial health and positive operational trends, including robust Q1 2026 earnings and favorable foot traffic patterns. However, the insider selling could have overshadowed these positive aspects in the eyes of investors.
• The shareholder approval of key proposals at the recent Annual Meeting, including the election of directors and executive compensation plan, indicates confidence in the company's leadership and strategic direction. However, the market sentiment today seems to have been influenced more by the insider selling activity.
• Overall, while the company's fundamentals remain strong, the bearish market movement today was likely driven by the significant insider selling by J. Robert Kerrey, creating a temporary negative sentiment among investors.

06.04.2026 - THC Stock was up 5.1%

• Following the strong Q1 2026 earnings announcement, THC's stock experienced a positive uptick in trading.
• Demonstrating impressive financial performance, the company exceeded EPS projections, highlighting operational strength.
• Despite hurdles such as volume pressures, Tenet Healthcare's emphasis on strategic cost management and outpatient services has been instrumental in driving favorable outcomes.
• Market sentiment remained largely optimistic in response to the company's strong earnings and future prospects, despite varied analyst price target adjustments.

11.05.2026 - THC Stock was up 6.6%

• Despite technical analysis pointing towards a "Strong Sell" sentiment and bearish momentum, THC saw a significant bullish surge in the market today.
• A credit upgrade to Ba2 by Moody's, coupled with a stable outlook, showcased Tenet Healthcare's successful debt reduction efforts and strong EBITDA, underscoring its emphasis on ambulatory care.
• The recent positive credit upgrade and robust Q1 2026 performance may have instilled greater investor confidence in THC, driving the bullish market movement.
• Investors are advised to remain vigilant about potential risks such as subdued future earnings projections, elevated leverage, and insider selling, notwithstanding the favorable developments.